Dr Reddys Laboratories Ltd share price logo

Dr Reddys Laboratories Ltd

NSE: DRREDDY

BSE: 500124

Mid Cap

Pharma Sector

₹1143.70

-1.30

(-0.11%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

🔔 Product Launch Alert

Dr. Reddy launches Nivolumab biosimilar Nivorz in India, manufactured at its Hyderabad facility.

What are INDmoney investors doing with Dr Reddys Laboratories shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-38%

Searches for Dr Reddys Laboratories on INDmoney have decreased by 38% over the last 30 days.

Investment activity on INDmoney

-56.63%

Investment activity in Dr Reddys Laboratories among INDmoney users has decreased by 56.63% over the last 30 days.

Among the most traded stocks

234th

Dr Reddys Laboratories was the 234th most traded stock on INDmoney over the last 7 days.

Average holding period of indmoney investors

52 days

INDmoney investors hold Dr Reddys Laboratories shares for an average of 52 days.

Key Events for Dr Reddys Laboratories

Last Dividend Declared

₹8.00 per share, declared on 12/05/2026

View Dividend History

Dr Reddys Laboratories Stock Performance

as on September 16, 2026 at 6:39 pm IST

  • Day's Low

    Day's High

    ₹1,133.90
    ₹1,149.90
    downward going graph

    0.86%

    Downside

    0.54%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,101.00
    ₹1,414.90
    downward going graph

    3.73%

    Downside

    23.71%

    Upside

    downward going graph

Dr Reddys Laboratories share price movements today

Previous Close
₹1,145.00
Open
₹1,143.40
Volume
5.85L
Upper Circuit
₹1,259.50
Lower Circuit
₹1,030.50
Day's Low - High
₹1,133.90 - ₹1,149.90
52 Week Low - High
₹1,101.00 - ₹1,414.90

Dr Reddys Laboratories Historical Returns

1 Month Return
-3.94 %
3 Month Return
-10.33 %
1 Year Return
-12.62 %
3 Year Return
-0.05 %
5 Year Return
+ 16.08 %

Dr Reddys Laboratories Fundamentals

as on September 16, 2026 at 1:09 pm IST

Market Cap

₹95,570.89 Cr

Return on Equity (ROE)

10.69

PE Ratio (TTM)

30.12

Return on capital employed (ROCE)

12.59

Industry PE ratio

51.81

Beta (LTM)

0.51

P/B Ratio

3.32

Dividend Yield

0.64

PEG Ratio

-1.02

Quarterly Earnings Growth YOY

-69.1

EPS (TTM)

49.79

Book Value

455.96

Dr Reddys Laboratories Stock Valuation

as on September 16, 2026 at 1:09 pm IST

Dr Reddys Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (3.37x)

October 27, 2019

Today (30.12x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (53.88x)

December 18, 2020

LowHigh

Today’s Price to Earnings Ratio: 30.12x

Dr Reddys Laboratories Technical Analysis

Track how Dr Reddys Laboratories technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish9
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
-0.18
Bullish
CCI (20)
-51.53
Neutral
RSI (14)
50.42
Neutral
Momentum (10)
0
Bullish
ADI (14)
22.77
Neutral
Ultimate Oscillator (7,14,28)
54.89
Neutral

Moving Averages

Name

Value

Action

SMA (20)
1142.81
Bullish
EMA (20)
1143.08
Bullish
VWMA (20)
1142.94
Bullish
SMA (50)
1143.49
Bearish
EMA (50)
1143.02
Bullish
SMA (200)
1141.95
Bullish
EMA (200)
1142.81
Bullish
KAMA (200)
1143.5
Bearish
DEMA (200)
1141.12
Bullish

Dr Reddys Laboratories Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr Reddys Laboratories with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Dr Reddys Laboratories Ltd image
Dr Reddys Laboratories Ltd
HOLD95,570.893.22%0.594,15733,700
Divis Laboratories Ltd image
Divis Laboratories Ltd
BUY2,44,178.0015.6%0.522,56810,560
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,84,478.4142.29%0.872,13819,274
Biocon Ltd image
Biocon Ltd
HOLD62,254.320.28%0.6836816,927
Gland Pharma Ltd image
Gland Pharma Ltd
BUY47,778.89-5.68%0.521,0276,430
See all

Market expectation of Dr Reddys Laboratories Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

HOLD

36.11%

Buy

25.00%

Hold

38.89%

Sell

Dr Reddys Laboratories Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
6,880.2
7,214.8
7,083
7,672.7
8,016.1
8,358.6
8,506
8,545.2
8,804.9
8,727
7,516.2
8,070.5
Other Income
319.2
218.9
201
193.1
313.6
154.4
527.6
290.5
330.2
271.1
480
355.5
Total Income
7,221.8
7,455.7
7,314.8
7,889.2
8,351.8
8,535.6
9,056
8,862.6
9,158.5
9,024.5
8,026.4
8,455.3
Expenses
4,894.3
5,213.7
5,282.6
5,566.2
5,961.7
6,108.2
6,530.5
6,398.5
6,818.4
6,865.9
7,163.9
7,239.9
Operating Profit
1,985.9
2,001.1
1,800.4
2,106.5
2,054.4
2,250.4
1,975.5
2,146.7
1,986.5
1,861.1
352.3
830.6
Operating Profit Margin %
28.86%
27.74%
25.42%
27.45%
25.63%
26.92%
23.22%
25.12%
22.56%
21.33%
4.69%
10.29%
Profit Before Interest, Tax and Depreciation
2,327.5
2,242
2,032.2
2,323
2,390.1
2,427.4
2,525.5
2,464.1
2,340.1
2,158.6
862.5
1,215.4
Interest
35.3
39.4
59.3
59.8
75.7
81.7
65.6
83
90.7
94.4
105.7
125.5
Depreciation
375.5
373.5
367.7
380.6
397
471.4
454.7
476.1
504.6
521
557.1
536.6
Profit Before Tax
1,916.7
1,829.1
1,605.2
1,882.6
1,917.4
1,874.3
2,005.2
1,905
1,744.8
1,543.2
199.7
553.3
Tax Paid
434.5
448.2
295.4
490.2
575.5
470.1
418.5
495.1
408
353.6
-21.6
117.7
Profit After Tax
1,482.2
1,380.9
1,309.8
1,392.4
1,341.9
1,404.2
1,586.7
1,409.9
1,336.8
1,189.6
221.3
435.6
Total Net profit including share of profit / Loss from associate company
1,482.2
1,380.9
1,309.8
1,392.4
1,341.9
1,404.2
1,586.7
1,409.9
1,336.8
1,189.6
221.3
435.6
EPS
89.09
82.94
78.66
83.61
75.4
16.97
19.12
17.04
16.18
14.53
2.65
5.33
Actual EPS
89.09
82.94
78.66
83.61
75.4
16.97
19.12
17.04
16.18
14.53
2.65
5.33
Adjusted EPS
17.82
16.59
15.73
16.72
15.08
16.97
19.12
17.04
16.18
14.53
2.65
5.33
Diluted EPS
88.91
82.81
78.53
83.48
75.25
16.94
19.1
17.02
16.18
14.52
2.65
5.33

Dr Reddys Laboratories Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
14,202.8
15,385.1
17,460
18,972.2
21,439.1
24,587.9
27,916.4
32,553.5
33,593.3
Other Income
155.2
381.3
676.7
339.4
554.7
1,092.5
909
1,119
1,371.8
Total Income
14,436.2
15,829.5
18,193.7
19,386.9
22,099.9
25,762.2
28,920.1
33,762.9
35,072
Expenses
11,929.8
12,270
15,046.6
15,177.6
17,777.5
18,320.7
20,078
24,096.8
27,246.7
Operating Profit
2,273
3,115.1
2,413.4
3,794.6
3,661.6
6,267.2
7,838.4
8,456.7
6,346.6
Operating Profit Margin %
16%
20.25%
13.82%
20%
17.08%
25.49%
28.08%
25.98%
18.89%
Profit Before Interest, Tax and Depreciation
2,506.4
3,559.5
3,147.1
4,209.3
4,322.4
7,441.5
8,842.1
9,666.1
7,825.3
Interest
78.8
88.9
98.3
97
95.8
142.8
171.1
282.9
373.8
Depreciation
1,077.2
1,134.8
1,163.1
1,228.8
1,165.2
1,250.2
1,470
1,703.7
2,058.8
Profit Before Tax
1,350.4
2,335.8
1,885.7
2,883.5
3,061.4
6,048.5
7,201
7,679.5
5,392.7
Tax Paid
438
385.8
-140.3
931.9
878.9
1,541.2
1,623.1
1,954.3
1,235.1
Profit After Tax
912.4
1,950
2,026
1,951.6
2,182.5
4,507.3
5,577.9
5,725.2
4,157.6
Total Net profit including share of profit / Loss from associate company
946.8
1,950
2,026
1,951.6
2,182.5
4,507.3
5,577.9
5,725.2
4,157.6
EPS
57.08
117.53
122.22
117.67
131.57
271.47
335.22
67.89
50.41
Actual EPS
57.08
117.53
122.22
117.67
131.57
271.47
335.22
67.89
50.41
Adjusted EPS
11.42
23.51
24.44
23.53
26.31
54.29
67.04
67.89
50.41
Diluted EPS
56.96
117.33
121.99
117.34
131.21
270.9
334.59
67.79
50.35

Dr Reddys Laboratories Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
3,262.6
2,144.4
1,803
2,870.4
2,984.1
3,570.3
2,810.8
5,887.5
4,543.3
4,642.8
5,673.7
Cash Flow from Investing Activities
-1,609.9
-1,889.6
-1,482.6
-769.2
-494.8
-1,280.6
-1,099.4
-4,108.7
-4,034.2
-5,785.3
-6,425.2
Cash Flow from Financing Activities
-1,700.1
-369.1
-444
-2,132.6
-2,515.9
-29.8
-242.2
-2,686.1
-376.3
1,891.1
829
Net Cash Flow
-47.4
-114.3
-123.6
-31.4
-26.6
1,285.8
3.2
-907.3
132.8
748.6
77.5

Dr Reddys Laboratories Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
26.65%
26.65%
26.65%
26.64%
26.64%
26.64%
26.64%
26.64%
26.64%
26.63%
26.64%
DII
16.21%
18.31%
20.73%
21.48%
22.9%
25.62%
26.74%
27.98%
30.44%
30.72%
31.74%
FII
0%
44.49%
42.27%
41.75%
40.08%
37.29%
36.36%
35.52%
33.2%
33.08%
32.07%
Public
10.57%
10.38%
10.19%
9.97%
10.22%
10.15%
10%
9.61%
9.47%
9.33%
9.35%
Total Outstanding Shares
16,68,09,397
16,68,18,266
16,68,29,701
16,68,76,946
83,44,23,960
83,44,55,365
83,45,81,775
83,46,13,760
83,46,30,355
83,46,56,970
83,46,75,800
Total Shareholders
2,57,794
2,55,500
2,67,694
3,10,403
4,03,669
4,59,605
4,51,929
4,49,216
4,55,243
4,49,665
4,46,086

Mutual Funds Buying / Exiting Dr Reddys Laboratories

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Dr Reddys Laboratories

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

ICICI Prudential India Opportunities Fund Direct Growth

ICICI Prudential India Opportunities Fund Direct Growth

₹897.20 Cr

₹664.63 Cr (+285.78%)

2.36%

ICICI Prudential Large Cap Fund Direct Plan Growth

ICICI Prudential Large Cap Fund Direct Plan Growth

₹720.25 Cr

₹75.51 Cr (+11.71%)

0.91%

Mutual Funds Exiting Dr Reddys Laboratories

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Dr Reddys Laboratories Corporate Actions

View detailed summary of the earnings and dividend history of Dr Reddys Laboratories.

  • Dr Reddys Laboratories Ltd Earnings Results

    Dr Reddys Laboratories Ltd’s net profit fell -68.67% since last year same period to ₹444.30Cr in the Q1 2026-2027. On a quarterly growth basis, Dr Reddys Laboratories Ltd has generated 101.13% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Dr Reddys Laboratories Ltd Dividends May,2026

    In the quarter ending March 2026, Dr Reddys Laboratories Ltd has declared dividend of ₹8.00 per share on 12 May 2026 - translating a dividend yield of 0.69%.

    Read More about Dividends

Indices Featuring Dr Reddys Laboratories Stock

Check stock indices that include Dr Reddys Laboratories.

BSE MFG

₹1,047.70

+8.00 (▲0.77%)

Nifty100 Eq Weig

₹33,533.55

+194.25 (▲0.58%)

Nifty 200

₹13,514.55

+72.30 (▲0.54%)

NIFTY 50

₹23,274.05

+155.45 (▲0.67%)

S&P BSE Low Volatility

₹1,685.43

+11.69 (▲0.70%)

Nifty100 Quality

₹5,451.80

+25.80 (▲0.48%)

BSE Healthcare

₹50,365.35

-113.46 (▲0.22%)

S&P BSE 250 LargeMidCap

₹10,424.03

+53.51 (▲0.52%)

Nifty LargeMidcap 250

₹16,153.40

+65.95 (▲0.41%)

BSE 200

₹10,929.71

+59.70 (▲0.55%)

Nifty 500

₹22,580.85

+103.40 (▲0.46%)

Nifty Healthcare

₹16,257.30

-41.70 (▲0.26%)

Nifty100 Low Volatility 30

₹19,332.35

+99.35 (▲0.52%)

NIFTY 100

₹24,344.85

+151.85 (▲0.63%)

NIFTY PHARMA

₹26,107.45

-80.95 (▲0.31%)

S&P BSE Dividend Stability

₹995.48

+6.72 (▲0.68%)

S&P BSE SENSEX 50

₹24,423.56

+152.80 (▲0.63%)

S&P BSE 100 ESG

₹395.91

+2.43 (▲0.62%)

S&P BSE 100 LargeCap TMC

₹8,778.54

+53.20 (▲0.61%)

BSE 100

₹24,931.24

+151.64 (▲0.61%)

BSE 500

₹35,330.72

+161.10 (▲0.46%)

Insights on Dr Reddys Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 220.9 Cr → 444.3 Cr (in ₹), with an average increase of 50.3% per quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 26.63% to 26.64% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 9.33% to 9.35% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 8.02K Cr → 8.45K Cr (in ₹), with an average increase of 5.1% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 21.14% to 20.66% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 13.19% to 13.16% in Jun 2026 quarter

Dr Reddys Laboratories Stock Futures & Options Contracts

View the latest movement in Dr Reddys Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.

Dr Reddys Laboratories Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DRREDDY 29 Sep ₹1300 Call
September 29, 2026
₹1300
₹0.4
-0.15
-27.27%
DRREDDY 29 Sep ₹1200 Call
September 29, 2026
₹1200
₹3
-0.8
-21.05%
DRREDDY 29 Sep ₹1150 Call
September 29, 2026
₹1150
₹12.55
-2.4
-16.05%
DRREDDY 29 Sep ₹1170 Call
September 29, 2026
₹1170
₹7
-1.6
-18.6%

Dr Reddys Laboratories Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
DRREDDY 29 Sep Fut
September 29, 2026
-
₹1138.6
-3.77
-0.33%
DRREDDY 27 Oct Fut
October 27, 2026
-
₹1135.6
-4.56
-0.4%
DRREDDY 23 Nov Fut
November 23, 2026
-
₹1136
-1.82
-0.16%

About Dr Reddys Laboratories Ltd

Dr Reddy's Laboratories Ltd was founded in 1984 and is based in Hyderabad, India. It is a pharmaceutical company that is listed on the Bombay Stock Exchange and National Stock Exchange of India. It has operations in over 60 countries and offers a wide range of products and services in the pharmaceuticals and healthcare sectors. The company has a strong focus on research and development and has over 6,000 employees worldwide.

Dr Reddy's Laboratories Ltd has a diverse portfolio of products and services, including prescription drugs, generic drugs, over-the-counter drugs, active pharmaceutical ingredients, biotechnology products, and nutraceuticals. Its most popular products include antibiotics, anti-infectives, anti-diabetics, anti-cancer, cardiovascular, gastrointestinal, and dermatology products. Some of its popular brands include Omez, Ciprocin, and Revital. It also has a strong presence in the generics market with its brands such as Reditux and Reditux-D.

Revenue: ₹8,070.50Cr as on June 2026 (Q1 FY27)
Net Profit: ₹435.60Cr as on June 2026 (Q1 FY27)
Listing date: 03 Nov, 1994
Chairperson Name: K Satish Reddy
OrganisationDr Reddys Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOK Satish Reddy
E-voting on sharesClick here to vote

FAQs

What is Dr Reddys Laboratories share price today?

Dr Reddys Laboratories share price today stands at ₹1143.7 as on . Dr Reddys Laboratories share today touched a day high of ₹1149.9 and a low of ₹1133.9.

What is the 52 week high and 52 week low range for Dr Reddys Laboratories share?

Dr Reddys Laboratories touched a 52 week high of ₹1414.9 and a 52 week low of ₹1101. Dr Reddys Laboratories share price today i.e. is trending at ₹1143.7, which is -19.17% down from its 52 week high and 3.88% up from its 52 week low.

What is Dr Reddys Laboratories's market capitalisation today?

Dr Reddys Laboratories market capitalisation is ₹95,570.89 Cr as on .

How to buy Dr Reddys Laboratories shares?

To buy Dr Reddys Laboratories shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for DRREDDY or Dr Reddys Laboratories Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Dr Reddys Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Dr Reddys Laboratories trading volume today?

Dr Reddys Laboratories trading volume is 5.85L as on . This means that 5.85L shares of Dr Reddys Laboratories were bought and sold on the stock market during today's trading session.

What are INDmoney investors doing with Dr Reddys Laboratories shares right now?

Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Dr Reddys Laboratories have both decreased over the past 30 days, and the average INDmoney investor holds the stock for 52 days. This reflects platform activity only and is not investment advice.